News : Press Release

Salius Pharma decided to double its Selenium Sulfide Bulk Drug Production Amid Global Demand soaring

“Expansion to serve key markets in South and Central America, Africa and Central and Southeast Asia”

Mumbai, India – March 26, 2025 —

As part of a strategic initiative to capitalize on the rapidly expanding global demand for Selenium Sulfide API, Salius Pharma—one of India’s leading suppliers of pharmaceutical active ingredients—announced today that its Board of Directors has approved a major expansion of its production capacity across India.

The company plans to double its Selenium Sulfide production within the next three quarters, significantly strengthening its global supply capabilities.

Selenium Sulfide is a key dermatological active pharmaceutical ingredient (API), widely used in anti-dandruff shampoos, medicated creams, and treatments for seborrheic dermatitis and tinea versicolor. Global demand for Selenium Sulfide has been steadily increasing, particularly in developing markets, where rising consumer awareness around scalp and skin health is driving demand for effective dermatological treatments.

“The move to double our production of Selenium Sulfide is a direct response to continuous global demand from the pharmaceutical and personal care markets,” stated acompany spokesperson for Salius Pharma.

“We believe in maintaining uninterrupted, high-quality supply to our partners around the globe.”

 Focused Global Expansion

Salius Pharma sees Latin America, Africa, and Southeast and Central Asia as prime growth regions. It is already established as one of the largest export bases for Selenium Sulfide in India, and the expansion capacity will further improve its sensitivity to the regional needs and regulation. The upgrade in production will be done at GMP compliant manufacturing units of Salius Pharma across India with state-of-the-art quality control systems to ensure that global standards are adhered to, including USFDA, WHO-GMP, and ISO certifications.

 Reputable API Supply Partner

Famous for technical consistency, Salius Pharma provides micronized BP/USP compliant and technical-grade Selenium Sulfide, serving formulators of OTC and prescription dermatology products. Competitive pricing and custom packaging abilities of the company have established it as a top choice among cosmetic and generic pharma manufacturers globally.

This growth is also in line with Salius Pharma’s long-term vision to be a worldwide partner in dermatological APIs and cost-effective healthcare solutions while building high-quality active ingredient availability in underserved markets.

Media Contact:

 Email: info@saliuspharma.com

 Website: https://saliuspharma.com

Phone: +91-8425880640